ATE478659T1 - Mehrlagiges arzneimittelausbringsystem mit sperre gegen reservoirmaterialfluss - Google Patents

Mehrlagiges arzneimittelausbringsystem mit sperre gegen reservoirmaterialfluss

Info

Publication number
ATE478659T1
ATE478659T1 AT06759664T AT06759664T ATE478659T1 AT E478659 T1 ATE478659 T1 AT E478659T1 AT 06759664 T AT06759664 T AT 06759664T AT 06759664 T AT06759664 T AT 06759664T AT E478659 T1 ATE478659 T1 AT E478659T1
Authority
AT
Austria
Prior art keywords
delivery system
material flow
block against
reservoir material
medicinal delivery
Prior art date
Application number
AT06759664T
Other languages
English (en)
Inventor
Rolf Jansen
Dina Coronado
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ATE478659T1 publication Critical patent/ATE478659T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive plasters or dressings
    • A61F13/0203—Adhesive plasters or dressings having a fluid handling member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive plasters or dressings
    • A61F13/0276—Apparatus or processes for manufacturing adhesive dressings or bandages
    • A61F2013/0296—Apparatus or processes for manufacturing adhesive dressings or bandages for making transdermal patches (chemical processes excluded)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T156/00—Adhesive bonding and miscellaneous chemical manufacture
    • Y10T156/10—Methods of surface bonding and/or assembly therefor
    • Y10T156/1052—Methods of surface bonding and/or assembly therefor with cutting, punching, tearing or severing
    • Y10T156/1082—Partial cutting bonded sandwich [e.g., grooving or incising]
AT06759664T 2005-05-13 2006-05-12 Mehrlagiges arzneimittelausbringsystem mit sperre gegen reservoirmaterialfluss ATE478659T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68090505P 2005-05-13 2005-05-13
US79023606P 2006-04-07 2006-04-07
PCT/US2006/018426 WO2006124584A2 (en) 2005-05-13 2006-05-12 Multilayer drug delivery system with barrier against reservoir material flow

Publications (1)

Publication Number Publication Date
ATE478659T1 true ATE478659T1 (de) 2010-09-15

Family

ID=36928681

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06759664T ATE478659T1 (de) 2005-05-13 2006-05-12 Mehrlagiges arzneimittelausbringsystem mit sperre gegen reservoirmaterialfluss

Country Status (10)

Country Link
US (3) US8632800B2 (de)
EP (3) EP1895994B1 (de)
AT (1) ATE478659T1 (de)
CY (1) CY1111436T1 (de)
DE (1) DE602006016441D1 (de)
DK (1) DK1895994T3 (de)
HK (1) HK1157244A1 (de)
PL (1) PL1895994T3 (de)
PT (1) PT1895994E (de)
WO (2) WO2006124584A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1895994T3 (pl) * 2005-05-13 2011-02-28 Alza Corp Wielowarstwowy system podawania leków z barierą zabezpieczającą przed wypływaniem materiału ze zbiornika
US8383149B2 (en) * 2005-09-23 2013-02-26 Alza Corporation High enhancer-loading polyacrylate formulation for transdermal applications
WO2007035941A2 (en) * 2005-09-23 2007-03-29 Alza Corporation Transdermal galantamine delivery system
US20080226698A1 (en) * 2007-03-16 2008-09-18 Mylan Technologies, Inc. Amorphous drug transdermal systems, manufacturing methods, and stabilization
ES2692437T3 (es) * 2007-08-13 2018-12-03 Abuse Deterrent Pharmaceutical Llc Fármacos resistentes al abuso, método de uso y método de preparación
WO2010042152A2 (en) * 2008-10-06 2010-04-15 Mylan Technologies, Inc. Amorphous rotigotine transdermal system
KR101317158B1 (ko) * 2011-02-18 2013-10-15 조선대학교산학협력단 갈란타민 또는 그의 염을 함유하는 경피흡수제제
ES2851175T3 (es) 2013-02-05 2021-09-03 Purdue Pharma Lp Formulaciones farmacéuticas resistentes a manipulación
WO2015021031A1 (en) 2013-08-05 2015-02-12 Cam Med Llc Conformable patch pump
KR101485822B1 (ko) * 2014-01-22 2015-01-23 주식회사 대웅제약 도네페질 또는 그의 염을 함유하는 경피흡수제제
US10449201B2 (en) * 2015-08-17 2019-10-22 Alpha To Omega Pharmaceutical Consultants, Inc. Transdermal and/or topical delivery system comprising clobazam
DE102018216244A1 (de) * 2018-09-24 2020-03-26 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit Barriereschicht
ES2936735B2 (es) * 2021-09-20 2023-11-29 Paterna Jesus Paterna Dispositivo para preparar manualmente sistemas terapéuticos transdérmicos y procedimiento

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3493657A (en) 1961-03-14 1970-02-03 Mozes Juda Lewenstein Therapeutic compositions of n-allyl-14-hydroxy - dihydronormorphinane and morphine
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3598122A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3773955A (en) 1970-08-03 1973-11-20 Bristol Myers Co Analgetic compositions
GB1451994A (en) * 1973-07-20 1976-10-06 Smithe Machine Co Inc F L Method and apparatus for cutting and applying patches
US4214557A (en) * 1978-08-15 1980-07-29 Beach Corbett D Jr Pivoting wall type, four stroke, internal combustion, rotary engine
US4457933A (en) 1980-01-24 1984-07-03 Bristol-Myers Company Prevention of analgesic abuse
US4286592A (en) 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
US4314557A (en) 1980-05-19 1982-02-09 Alza Corporation Dissolution controlled active agent dispenser
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
US4464378A (en) 1981-04-28 1984-08-07 University Of Kentucky Research Foundation Method of administering narcotic antagonists and analgesics and novel dosage forms containing same
US4588580B2 (en) 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
US4626539A (en) 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
US4568343A (en) * 1984-10-09 1986-02-04 Alza Corporation Skin permeation enhancer compositions
US4806341A (en) 1985-02-25 1989-02-21 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
US5538736A (en) * 1987-04-28 1996-07-23 Lts Lohmann Therapie-Systeme Gmbh Active substance-containing plaster for the controlled administration of active substances to the skin
US4983395A (en) * 1987-11-12 1991-01-08 Theratech Inc. Device for administering an active agent to the skin or mucosa
US4849224A (en) * 1987-11-12 1989-07-18 Theratech Inc. Device for administering an active agent to the skin or mucosa
GB8728294D0 (en) 1987-12-03 1988-01-06 Reckitt & Colmann Prod Ltd Treatment compositions
US5236714A (en) 1988-11-01 1993-08-17 Alza Corporation Abusable substance dosage form having reduced abuse potential
US5350581A (en) * 1989-12-14 1994-09-27 Pharmetrix Corporation Method for manufacturing transdermal devices
DE4010079A1 (de) 1990-03-29 1991-10-02 Lohmann Therapie Syst Lts Pharmazeutische formulierung zur behandlung des alkoholismus
US5149538A (en) 1991-06-14 1992-09-22 Warner-Lambert Company Misuse-resistive transdermal opioid dosage form
KR950701516A (ko) * 1992-05-13 1995-04-28 에드워드 엘. 만델 옥시부티닌의 경피 투여(Transdermal Administration of Oxybutynin)
DE4301783C1 (de) 1993-01-23 1994-02-03 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Galanthamin als wirksamem Bestandteil
US6316439B1 (en) 1993-10-15 2001-11-13 Aventis Pharamaceuticals Inc. Galanthamine derivatives as acetylcholinesterase inhibitors
US6323195B1 (en) * 1993-10-15 2001-11-27 Aventis Pharmaceuticals Inc. Galanthamine derivatives as acetylcholinesterase inhibitors
US6323196B1 (en) 1993-10-15 2001-11-27 Aventis Pharmaceuticals Inc. Galanthamine derivatives as acetylcholinesterase inhibitors
DE19509663A1 (de) 1995-03-17 1996-09-19 Lohmann Therapie Syst Lts Verfahren zur Isolierung von Galanthamin
DE69614841T2 (de) * 1995-04-06 2002-04-11 Janssen Pharmaceutica Nv Verfahren zur Herstellung von Galanthaminderivate durch asymmetrische Reduktion
US5882676A (en) 1995-05-26 1999-03-16 Alza Corporation Skin permeation enhancer compositions using acyl lactylates
US5785991A (en) 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
US5693335A (en) 1995-06-07 1997-12-02 Cygnus, Inc. Skin permeation enhancer composition for use with sex steroids
GB9514821D0 (en) 1995-07-19 1995-09-20 Sod Conseils Rech Applic Galanthamine derivatives
GB9519268D0 (en) * 1995-09-21 1995-11-22 Chiroscience Ltd Preparation of alkaloids
GB9519267D0 (en) * 1995-09-21 1995-11-22 Chiroscience Ltd Preparation of alkaloids
EP0934078B1 (de) 1996-10-24 2002-12-18 Alza Corporation Penetrationsfördernde substanzen für die transdermale verabreichung von wirkstoffen, vorrichtungen und verfahren zur herstellung
SI1299104T1 (sl) 2000-02-08 2009-10-31 Euro Celtique Sa Oralne formulacije opioidnih agonistov, varne pred zlorabo
CN100508974C (zh) 2001-03-16 2009-07-08 阿尔扎公司 施用芬太尼的经皮贴剂
WO2002087482A1 (en) 2001-05-01 2002-11-07 Euro-Celtique Abuse resistant opioid containing transdermal systems
FR2826005B1 (fr) 2001-06-15 2004-07-16 Centre Nat Rech Scient Synthese totale de la galanthamine, de ses analogues et de ses derives
DE10129265A1 (de) * 2001-06-18 2003-01-02 Hf Arzneimittelforsch Gmbh Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie
US8440220B2 (en) * 2002-04-23 2013-05-14 Durect Corporation Transdermal analgesic systems with reduced abuse potential
US8524272B2 (en) * 2003-08-15 2013-09-03 Mylan Technologies, Inc. Transdermal patch incorporating active agent migration barrier layer
EP1898891A2 (de) 2005-05-13 2008-03-19 Alza Corporation System zur verabreichung mehrschichtiger arzneimittel mit sperre gegen antagonisten
PL1895994T3 (pl) 2005-05-13 2011-02-28 Alza Corp Wielowarstwowy system podawania leków z barierą zabezpieczającą przed wypływaniem materiału ze zbiornika

Also Published As

Publication number Publication date
PL1895994T3 (pl) 2011-02-28
US20060257462A1 (en) 2006-11-16
DK1895994T3 (da) 2010-12-20
HK1157244A1 (en) 2012-06-29
DE602006016441D1 (de) 2010-10-07
EP2316437A1 (de) 2011-05-04
US20140130973A1 (en) 2014-05-15
US20060257461A1 (en) 2006-11-16
PT1895994E (pt) 2010-12-03
EP1895994A2 (de) 2008-03-12
WO2006124584A3 (en) 2007-04-19
EP1895994B1 (de) 2010-08-25
CY1111436T1 (el) 2015-08-05
WO2006124585A2 (en) 2006-11-23
US8632800B2 (en) 2014-01-21
WO2006124585A3 (en) 2007-05-03
EP1895995A2 (de) 2008-03-12
EP2316437B1 (de) 2014-07-30
WO2006124584A2 (en) 2006-11-23

Similar Documents

Publication Publication Date Title
ATE478659T1 (de) Mehrlagiges arzneimittelausbringsystem mit sperre gegen reservoirmaterialfluss
WO2006124749A3 (en) Multilayer drug delivery system with barrier against antagonist exposure
WO2010042471A3 (en) Medical devices for delivery of therapeutic agents to body lumens
SMAP200900075A (it) Dispositivi terapeutici ibridi impiantabili
WO2007108970A3 (en) Infusion device with piston pump
DE602005009121D1 (de) Keramischer Verbundkörper mit intergrierter nachgiebiger Verschleissschicht
ATE419842T1 (de) Abgabevehikel mit nanoteilchen
DE602005027059D1 (de) Polymer-füllstoff-komposite für die kontrollierte abgabe von therapeutischen mitteln aus medizinischen artikeln
WO2007115039A3 (en) Multi-cartridge fluid delivery device
WO2009045784A3 (en) Disposable infusion device layered structure
BRPI0514834B8 (pt) processo de montagem de dispositivos de envio de fármaco e dispositivo de envio de fármaco
HK1184700A1 (en) Use of glycosaminoglycan containing a binded hydrophobic group in the preparation of medicine for treating or preventing corneal epithelial layer disorders
WO2006058234A3 (en) Medical devices with highly flexible coated hypotube
WO2006133101A3 (en) Agent delivery system
AR030557A1 (es) Una tableta en multicapa de liberacion controlada y metodo de tratamiento
ATE489123T1 (de) Medizinprodukte mit selbstformender ratenkontrollierender barriere für die arzneiabgabe
WO2007127815A3 (en) Microprojection array application with multilayered microprojection member for high drug loading
CL2008000461A1 (es) Uso de aclidinio en el tratamiento o prevencion de una enfermedad o un estado respiratorio en un paciente por inhalacion, sin producir en dicho paciente efectos antimuscarinicos sistemicos.
ATE477774T1 (de) Verabreichungskatheter mit einem transplantat- injektionsmechanismus
HK1142270A1 (en) Silibinin component for the treatment of hepatitis
WO2009046369A3 (en) Use of a specific dosage regimen of ifn-alpha and ribavirin for treating hepatitis c
FR2934773B1 (fr) Lit de malade a barriere laterale facilitant la levee du patient.
DE60311449D1 (de) Transdermales therapeutisches system mit zwei übereinanderliegenden matrixschichten, die verschiedene affinitäten zum enthaltenen wirkstoff ausweisen
CL2008003133A1 (es) Uso de albumina humana para la preparacion de un medicamento para el tratamiento de desordenes cognitivos en pacientes de alzheimer, donde el medicamento se encuentra en forma de solucion para recambio plasmatico y/o perfusion intravenosa.
ATE505323T1 (de) Behälter für medizinische flüssigkeiten mit hoher wasserdampfsperre

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1895994

Country of ref document: EP